Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

PRHSX vs. HCPIX: which is better?

Bottom line

PRHSX vs HCPIX: the short answer

PRHSX (T. Rowe Price Health Sciences Fund, Inc.) and HCPIX (Health Care Ultrasector Profund) share a meaningful slice of their top holdings — about 65% by weight.

But PRHSX is far broader, holding 279 positions to 69 for HCPIX, so beyond the top names it adds exposure HCPIX doesn't have.

PRHSX is cheaper at 0.83% vs 1.76% — a difference of $93 a year per $10,000 invested.

Over five years, HCPIX returned +6.4% a year vs +4.2% for PRHSX (reporting dates differ).

Updated Nov 19, 2026

PRHSX vs HCPIX side by side

PRHSXHCPIX
TypeMutual fundMutual fund
Fund familyT. Rowe PriceProShares
CategoryHealth Care SectorHealth Care Sector
Expense ratio0.83%1.76%
Annual cost per $10k$83$176
10-yr cost on $10k (prospectus)$1,025$2,073
Max front load——
12b-1 fee—0%
1-yr return+17.7%−1.4%
5-yr return (annualized)+4.2%+6.4%
10-yr return (annualized)+9.1%+9.2%
Best quarter+23.5%+22.0%
Worst quarter−15.8%−21.0%
Net assets (fund)$11.9B$12.1M
Number of holdings27969
Portfolio turnover62%99%
Returns as ofDec 31, 2025Dec 31, 2024

Source: SEC Form N-PORT and fund prospectuses

Year-by-year returns

YearPRHSXHCPIXDifference
2024+1.8%−1.4%+3.2%
2023+3.1%−1.3%+4.4%
2022−12.2%−10.6%−1.6%
2021+13.3%+33.9%−20.7%
2020+30.1%+16.9%+13.3%
2019+29.1%+28.4%+0.7%
2018+1.2%+5.0%−3.7%
2017+28.0%+32.2%−4.2%
2016−10.4%−6.5%−3.8%

Source: Fund prospectus bar charts

Holdings overlap

16 of PRHSX's top 25 holdings also appear in HCPIX's top 25.

Shared top holdings
HoldingPRHSXHCPIX
Eli Lilly & Co14.28%11.83%
Johnson & Johnson6.63%8.03%
Unitedhealth Group Inc5.99%4.90%
Abbvie Inc5.10%5.77%
Merck & Co. Inc.4.01%4.19%
Gilead Sciences Inc2.82%2.10%
Thermo Fisher Scientific Inc2.52%2.78%
Vertex Pharmaceuticals Inc2.28%1.57%
Bristol-myers Squibb Co2.11%1.74%
Abbott Laboratories1.89%2.40%
Intuitive Surgical Inc1.87%1.63%
Amgen Inc1.82%2.71%
Stryker Corp1.78%1.46%
Elevance Health Inc1.53%1.06%
Danaher Corp1.43%1.60%

Source: SEC Form N-PORT

PRHSX top 10

  1. Eli Lilly & Co — 14.28%
  2. Johnson & Johnson — 6.63%
  3. Unitedhealth Group Inc — 5.99%
  4. Abbvie Inc — 5.10%
  5. Merck & Co. Inc. — 4.01%
  6. Gilead Sciences Inc — 2.82%
  7. Thermo Fisher Scientific Inc — 2.52%
  8. Vertex Pharmaceuticals Inc — 2.28%
  9. Bristol-myers Squibb Co — 2.11%
  10. Abbott Laboratories — 1.89%

HCPIX top 10

  1. Eli Lilly & Company — 11.83%
  2. Johnson & Johnson — 8.03%
  3. N/a — 6.45%
  4. Abbvie Inc — 5.77%
  5. N/a — 4.97%
  6. Unitedhealth Group Inc — 4.90%
  7. Merck & Company Inc — 4.19%
  8. N/a — 3.96%
  9. N/a — 3.96%
  10. N/a — 3.11%

FAQ

What is the difference between PRHSX and HCPIX?
PRHSX (T. Rowe Price Health Sciences Fund, Inc.) and HCPIX (Health Care Ultrasector Profund) share a meaningful slice of their top holdings — about 65% by weight. But PRHSX is far broader, holding 279 positions to 69 for HCPIX, so beyond the top names it adds exposure HCPIX doesn't have.
Which is cheaper, PRHSX or HCPIX?
PRHSX has the lower expense ratio (0.83%).
Should I own both PRHSX and HCPIX?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.